Data

Efficacy of assigning treatment for participants with Chronic Myelomonocytic Leukaemia based on their individual molecular results (lenzilumab plus azacitidine versus sodium ascorbate plus azacitidine). PREACH-M: PREcision Approach to CHronic Myelomonocytic Leukaemia.

Health Data Australia Contributor Records

Thomas, A/Prof Dan ; A/Prof Daniel Thomas

Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]

ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58138/GJZ0-HF61&rft.title=Efficacy of assigning treatment for participants with Chronic Myelomonocytic Leukaemia based on their individual molecular results (lenzilumab plus azacitidine versus sodium ascorbate plus azacitidine). PREACH-M: PREcision Approach to CHronic Myelomonocytic Leukaemia.&rft.identifier=http://doi.org/10.58138/GJZ0-HF61&rft.publisher=South Australian Health and Medical Research Institute&rft.description=HeSANDA 1.0.0&rft.creator=Thomas, A/Prof Dan &rft.creator=A/Prof Daniel Thomas &rft.date=2029&rft.relation=http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12621000223831&rft.coverage=NSW, SA, WA, QLD and VIC&rft_subject=FOS: Medical and health sciences&rft.type=dataset&rft.language=English Access data via landing page

Cite Saved to MyRDA Save to MyRDA

Full description

HeSANDA 1.0.0

Collected:

Data time period: 2021 2028

This dataset is part of a larger collection

Click to explore relationships graph

Spatial Coverage And Location

text: NSW, SA, WA, QLD and VIC

Subjects

FOS: Medical and health sciences |

User Contributed Tags

Login to tag this record with meaningful keywords to make it easier to discover

Other Information

Medical Research Future Fund

Crossref Funder ID : https://doi.org/10.13039/501100025520

Identifiers

DOI : 10.58138/GJZ0-HF61